Literature DB >> 31907377

Pathological assessment of endoscopic resections of the gastrointestinal tract: a comprehensive clinicopathologic review.

M Priyanthi Kumarasinghe1, Michael J Bourke2, Ian Brown3,4, Peter V Draganov5, Duncan McLeod6, Catherine Streutker7, Spiro Raftopoulos8, Tetsuo Ushiku9, Gregory Y Lauwers10.   

Abstract

Endoscopic resection (ER) allows optimal staging with potential cure of early-stage luminal malignancies while maintaining organ preservation. ER and surgery are non-competing but complementary therapeutic options. In addition, histological examination of ER specimens can either confirm or refine the pre-procedure diagnosis. ER is used for the treatment of Barrett's related early carcinomas and dysplasias, early-esophageal squamous cell carcinomas and dysplasias, early gastric carcinomas and dysplasia, as well as low-risk submucosal invasive carcinomas (LR-SMIC) and, large laterally spreading adenomas of the colon. For invasive lesions, histological risk factors predict risk of lymph node metastasis and residual disease at the ER site. Important pathological risk factors predictive of lymph node metastasis are depth of tumor invasion, poor differentiation, and lymphovascular invasion. Complete resection with negative margins is critical to avoid local recurrences. For non-invasive lesions, complete resection is curative. Therefore, a systematic approach for handling and assessing ER specimens is recommended to evaluate all above key prognostic features appropriately. Correct handling starts with pinning the specimen before fixation, meticulous macroscopic assessment with orientation of appropriate margins, systematic sectioning, and microscopic assessment of the entire specimen. Microscopic examination should be thorough for accurate assessment of all pathological risk factors and margin assessment. Site-specific issues such as duplication of muscularis mucosa of the esophagus, challenges of assessing ampullectomy specimens and site-specific differences of staging of early carcinomas throughout the gastrointestinal tract (GI) tract should be given special consideration. Finally, a standard, comprehensive pathology report that allows optimal staging with potential cure of early-stage malignancies or better stratification and guidance for additional treatment should be provided.

Entities:  

Mesh:

Year:  2020        PMID: 31907377     DOI: 10.1038/s41379-019-0443-1

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  88 in total

1.  How to justify endoscopic submucosal dissection in the Western world.

Authors:  J J Bergman
Journal:  Endoscopy       Date:  2009-10-28       Impact factor: 10.093

2.  Colorectal endoscopic submucosal dissection: when and by whom?

Authors:  Michael J Bourke; Horst Neuhaus
Journal:  Endoscopy       Date:  2014-07-25       Impact factor: 10.093

3.  Clinicopathologic factors and molecular markers related to lymph node metastasis in early gastric cancer.

Authors:  Eun Hyo Jin; Dong Ho Lee; Sung-Ae Jung; Ki-Nam Shim; Ji Yeon Seo; Nayoung Kim; Cheol Min Shin; Hyuk Yoon; Hyun Chae Jung
Journal:  World J Gastroenterol       Date:  2015-01-14       Impact factor: 5.742

4.  Endoscopic management of Barrett's esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement.

Authors:  Bas Weusten; Raf Bisschops; Emanuel Coron; Mário Dinis-Ribeiro; Jean-Marc Dumonceau; José-Miguel Esteban; Cesare Hassan; Oliver Pech; Alessandro Repici; Jacques Bergman; Massimiliano di Pietro
Journal:  Endoscopy       Date:  2017-01-25       Impact factor: 10.093

Review 5.  Risk of lymph node metastasis in T1 carcinoma of the colon and rectum.

Authors:  Riccardo Nascimbeni; Lawrence J Burgart; Santhat Nivatvongs; Dirk R Larson
Journal:  Dis Colon Rectum       Date:  2002-02       Impact factor: 4.585

Review 6.  The risk of lymph-node metastases in patients with high-grade dysplasia or intramucosal carcinoma in Barrett's esophagus: a systematic review.

Authors:  Kerry B Dunbar; Stuart Jon Spechler
Journal:  Am J Gastroenterol       Date:  2012-06       Impact factor: 10.864

Review 7.  Australian clinical practice guidelines for the diagnosis and management of Barrett's esophagus and early esophageal adenocarcinoma.

Authors:  David C Whiteman; Mark Appleyard; Farzan F Bahin; Yuri V Bobryshev; Michael J Bourke; Ian Brown; Adrian Chung; Andrew Clouston; Emma Dickins; Jon Emery; Guy D Eslick; Louisa G Gordon; Florian Grimpen; Geoff Hebbard; Laura Holliday; Luke F Hourigan; Bradley J Kendall; Eric Yt Lee; Angelique Levert-Mignon; Reginald V Lord; Sarah J Lord; Derek Maule; Alan Moss; Ian Norton; Ian Olver; Darren Pavey; Spiro Raftopoulos; Shan Rajendra; Mark Schoeman; Rajvinder Singh; Freddy Sitas; B Mark Smithers; Andrew C Taylor; Melissa L Thomas; Iain Thomson; Henry To; Jutta von Dincklage; Christine Vuletich; David I Watson; Ian F Yusoff
Journal:  J Gastroenterol Hepatol       Date:  2015-05       Impact factor: 4.029

Review 8.  Endoscopic and surgical resection of T1a/T1b esophageal neoplasms: a systematic review.

Authors:  George Sgourakis; Ines Gockel; Hauke Lang
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

9.  British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus.

Authors:  Rebecca C Fitzgerald; Massimiliano di Pietro; Krish Ragunath; Yeng Ang; Jin-Yong Kang; Peter Watson; Nigel Trudgill; Praful Patel; Philip V Kaye; Scott Sanders; Maria O'Donovan; Elizabeth Bird-Lieberman; Pradeep Bhandari; Janusz A Jankowski; Stephen Attwood; Simon L Parsons; Duncan Loft; Jesper Lagergren; Paul Moayyedi; Georgios Lyratzopoulos; John de Caestecker
Journal:  Gut       Date:  2013-10-28       Impact factor: 23.059

Review 10.  Tumor budding in upper gastrointestinal carcinomas.

Authors:  Viktor H Koelzer; Rupert Langer; Inti Zlobec; Alessandro Lugli
Journal:  Front Oncol       Date:  2014-08-14       Impact factor: 6.244

View more
  4 in total

Review 1.  Multimodal Imaging Mass Spectrometry: Next Generation Molecular Mapping in Biology and Medicine.

Authors:  Elizabeth K Neumann; Katerina V Djambazova; Richard M Caprioli; Jeffrey M Spraggins
Journal:  J Am Soc Mass Spectrom       Date:  2020-09-04       Impact factor: 3.262

2.  Clinicopathologic correlations of superficial esophageal adenocarcinoma in endoscopic submucosal dissection specimens.

Authors:  Sadhna Dhingra; Firas Bahdi; Sarah B May; Mohamed O Othman
Journal:  Diagn Pathol       Date:  2021-11-27       Impact factor: 2.644

3.  Is adjuvant chemotherapy necessary for early gastric cancer?

Authors:  Yu Mei; Tienan Feng; Min Yan; Zhenggang Zhu; Zhenglun Zhu
Journal:  Cancer Biol Med       Date:  2021-06-23       Impact factor: 5.347

4.  Fecal Enterotoxigenic Bacteroides fragilis-Peptostreptococcus stomatis-Parvimonas micra Biomarker for Noninvasive Diagnosis and Prognosis of Colorectal Laterally Spreading Tumor.

Authors:  Xiaonan Shen; Jialu Li; Jiaqi Li; Yao Zhang; Xiaobo Li; Yun Cui; Qinyan Gao; Xiaoyu Chen; Yingxuan Chen; Jing-Yuan Fang
Journal:  Front Oncol       Date:  2021-05-11       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.